Alvox Bio provides 3D bioprinting services to create customized tissue models for drug discovery and personalized medicine, utilizing advanced bio-materials and high-throughput in vitro techniques. This technology enables researchers and pharmaceutical companies to evaluate safety, toxicity, and therapeutic potential more accurately, accelerating the development of new therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional 2D cell cultures and animal models often fail to accurately predict human responses to drugs, leading to high failure rates in clinical trials and hindering the development of effective therapies. Current methods lack the complexity and physiological relevance needed to replicate the human body's microenvironment, resulting in inaccurate safety and efficacy evaluations. This gap between preclinical testing and clinical outcomes slows down drug discovery and increases development costs.
Solution
Alvox Bio provides 3D bioprinting services that create customized, multi-layered tissue models to improve drug discovery and personalized medicine. These models replicate the complexity of human tissues, incorporating multiple cell types, including cancer, stromal, and immune cells, to recreate tumor microenvironments with accuracy. By using advanced bio-materials and high-throughput in vitro techniques, Alvox Bio enables researchers and pharmaceutical companies to evaluate drug safety, toxicity, and therapeutic potential more effectively. The 3D-bioprinted tumor models offer enhanced reproducibility, scalability, and physiological relevance compared to traditional methods. Alvox Bio's platform supports rapid, large-scale production of precise 3D tissue models for a variety of research and clinical applications, bridging the gap between in vitro and in vivo studies.
Target Audience
Alvox Bio primarily serves researchers, pharmaceutical companies, and clinicians seeking advanced preclinical models for drug discovery, safety testing, and personalized medicine applications.
Features
- Customized 3D tissue models designed to replicate specific physiological environments
- Tailored bioprinting services for simple to complex tissue models, bioprinted products, and bioink development
- High-throughput in-vitro 3D tissue bioprinting platform for rapid, large-scale production
- Patient-derived tumor organoid models for personalized medicine
- Safety and toxicity studies using 3D bioprinted tissues derived from healthy donors
- Preclinical drug screening services including advanced phenotyping, functional assays, immunophenotyping, biomarker identification, histology, and cytokine analysis
- In vivo validation services to ensure the reliability and effectiveness of bioprinted tissues